Gene environment interaction

Journal of Epidemiology and Community Health

Volumn 50, Issue 4, 1996, Pages 397-400

  Campbell, H ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; CANCER; DIABETES MELLITUS; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FAMILY STUDY; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; RELATIVE; RISK ASSESSMENT; SHORT SURVEY; TWINS;

EID: 0029811480     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.50.4.397     Document Type: Short Survey

References (40)

1. Evans DAP. Pharmacogenetics. In: Emery AEH, Rimoin DL eds. Principles and practice of medical genetics. Vol 2. New York: Churchill, Livingstone, 1983; 1389-400.
2. Lenke RR, Levy HL. Maternal phenylketonuria and hyperphenylalalinemia. N Engl J Med 1980;303: 1202-8.
3. Khoury MJ, Beary TH, Cohen BH. The interface of genetics and epidemiology. J Chron Dis 1986;39: 963-78.
4. Tokuhata GK, Lilienfield AM. Familial aggregation of lung cancer in humans. J Natl Cancer Inst 1963;30: 289-312.
5. Caporaso NF, Tucker MA, Hoover RN. Lung cancer and the debrisoquine metabolic phenotype. J Natl Cancer Inst 1990;82: 1264-72.
6. Ooi WI, Elston RC, Chen VW. Increased familial risk for lung cancer. J Natl Cancer Inst 1986;76: 217-22.
7. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994;265: 2037-48.
8. Alper JS. Genetic complexity in single gene diseases. BMJ 1996;312: 196-7.
9. Wolf U. The genetic contribution to the phenotype. Hum Genet 1995;95: 127-48.
10. Ottman R. An epidemiologic approach to gene-environment interaction. Genet Epidemiol 1990;7: 177-85.
11. Ottman R, Susser E, Meisner M. Control for environmental risk factors in assessing genetic effects on disease familial aggregation. Am J Epidemiol 1991;134: 298-309.
12. Motulsky AG, Campbell-Krant JM. Population genetics of glucose-6 phosphate dehydrogenase deficiency of the red cell. In: Proceedings of the Conference on Genetic Polymorphisms and Geographic Variation in Disease. New York: Grune and Stratton, 1962; 159-91.
13. Strickler S, Dansky L, Anderman E, Spielberg S. Pharmacogenetic predisposition to phenytoin-induced birth defects. Pediatr Res 1985;19: 180A.
14. Woosley RL, Drayer DE, Reidenberg MM. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and lupus syndrome. N Engl J Med 1978;208: 1157-9.
15. Eichelbaum M, Kroemer HK, Mikus G. Genetically determined differences in drug metabolism as a risk factor in drug toxicity. Toxicol Lett 1992;64: 15-22.
16. Sellers TA, Anderson VE, Potter JD,et al. Epidemiologic and genetic follow-up study of 544 Minnesota breast cancer families: design and methods. Genet Epidemiol 1995;12: 417-29.
17. Motulsky AG (editorial). Genetic epidemiology. Genet Epidemiol 1984;1: 143-4.
18. Khoury MJ, Beaty TH, Cohen BH. Interaction of genetics and epidemiology in the literature. Genet Epidemiol 1986;3: 269-77.
19. Blackwelder WC, Elston RC. A comparison of sib-pair link-age tests for disease susceptibility loci. Genet Epidemiol 1985;2: 85-97.
20. Knapp M, Seuchter SA, Baur MP. The haplotype-relative-risk (HRR) method for analysis of association in nuclear families. Am J Hum Genet 1993;52: 1085-93.
21. Plomin R, Owen MJ, McGuffin P. The genetic basis of compex human behaviors. Science 1994;264: 1733-46.
22. Khoury MJ, Beaty, TH, Cohen BH. Fundamentals of genetic epidemiology. New York: Oxford University Press, 1993.
23. Hwang SJ, Beaty TH, Panny SR,et al. Association study of transforming growth gactor alpha (TGFα) Taql polymorphism and oral clefts: indication of gene-environmentiInteraction in a population-based sample of infants with birth defects. Am J Epidemiol 1995;41: 629-36.
24. Duijn CM, Haverkes LM, Van Broeckhoven C, de Knijkk P, Hofman A. Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease. BMJ 1995; 310: 627-31.
25. Hunt SC, Hasstedt SJ, Wu LL, Williams RR. A Gene-environment interaction between inferred kallikrein genotype and potassium. Hypertension 1993;22: 160-68.
26. Clerget-Darpoux F, Bonaiti-Pellie C. Strategies based on marker information for the study of human diseases. Ann Hum Genet 1992;56: 145-53.
27. Eaves LJ. The resolution of genotype environment interaction in segregation analysis of nuclear families. Genet Epidemiol 1984;1 215-28.
28. Mather K, Jinks JL. Biometrical genetics. The study of continuous variation. London: Chapman and Hall, 1982.
29. Vesell ES. Genetic and environmental factors causing variation in drug response. Mutat Res 1991;247: 241-57.
30. Khoury MJ, Stewart W, Beaty TH. Effect of genetic susceptibility on causal inference in epidemiologic studies. Am J Epidemiol 1987;126: 561-7.
31. Phillips PH, Linet MS, Harris EL. Assessment of family history information in case-control cancer studies. Am J Epidemiol 1991;133: 757-65.
32. McMichael AJ. Molecular epidemiology: new pathway or new travelling companion? Amer J Epidemiol 1994;140: 1-11.
33. Cooper DN, Clatton JF. DNA polymorphisms and the study of disease associations. Hum Genet 1988;78: 299-312.
34. Ottman R. An epidemiologic approach to gene-environment interaction. Genet Epidemiol 1990;7: 177-85.
35. Khoury MJ, Beaty TH. Applications of the case-control method in genetic epidemiology. Am J Epidemiol 1994;139: 134-49.
36. Hwang SJ, Beaty TH, Liang KY, Coresh J. Minimum sample size estimation to detect gene-environment interaction in case-control designs. Am J Epidemiol 1994;140: 1029-37.
37. Newman B, Moorman PG, Millikan R, Qaqish BF, Geradts J, Aldrich TE, Liu ET. The Carolina breast cancer study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat 1995;35: 51-60.
38. Khoury MJ, Flanders WD, Lipton RB. The afffected sib-pair method in the context of an epidemiologic study design. Genet Epidemiol 1991;8: 277-82.
39. Falk CT, Rubinstein P. Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Ann Hum Genet 1987;51: 227-33.
40. Cohen BH. Chronic obstructive pulmonary disease: A challenge in genetic epidemiology. Am J Epidemiol 1980;112: 274-88.